CBD – cannabidiol, a non-psychoactive component of the cannabis plant – has experienced a greater hype on the consumer market than almost any other product over the last two to three years.
Besides promising growth rates, the CBD consumer health market is a fragmented industry in upheaval, challenged by a confusing regulatory landscape.
The paper “New kid on the block? – Insights on CBD in the consumer health market” examines the when, where and how when it comes to planning an entry into the CBD consumer health market.
